David Schwartz is a partner in Smart & Biggar's Ottawa office. His practice focuses on patent law in the fields of biotechnology, pharmaceuticals, and chemistry, as well as plant breeders’ rights. David advises on regulatory matters relating to the Patented Medicines (Notice of Compliance) Regulations, data protection under the Food and Drug Regulations, and matters concerning the Patented Medicine Prices Review Board. He appears regularly in oral proceedings before the Patent Appeal Board and has handled first-to-invent conflicts under the pre-1989 Patent Act.
David has testified on patent law reform before both the House of Commons Standing Committee on Industry, Science and Technology and the Senate National Finance Committee, and has lectured on patent law at Queen’s University and the University of Ottawa.
In 2013 he was named LMG Life Sciences Canadian “Patent Attorney of the Year” and Best Lawyers 2016 Biotechnology Law "Lawyer of the Year" in Ottawa. David is listed in The Best Lawyers in Canada, LMG Life Sciences and Managing Intellectual Property’s IP Stars Handbook: Patents.
He is past-President of Intellectual Property Institute of Canada.
BSc Hons (Genetics); LLB (1991). Registered Patent and Trademark Agent. Called to the British Columbia Bar (1992), Alberta Bar (1993), Ontario Bar (2001).
Last updated 1st June 2018